Lv31
340 积分 2022-10-13 加入
Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours
14天前
已完结
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review
14天前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
14天前
已完结
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation
14天前
已完结
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
24天前
已完结
Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial
2个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2个月前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
2个月前
已完结
A Review of Recent Advances in the Molecular Mechanisms Underlying Brain Metastasis in Lung Cancer
3个月前
已完结
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
3个月前
已完结
皖公网安备34019202002308
